menu
    • menu

    Company profile for Alkermes Plc

    NEW Drugs in Dev: 17
    DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.

    Virtual Booth

    Contact Supplier

    Biophore is a research-driven global pharmaceutical company focused on niche APIs for the generic industry.

    Virtual Booth

    Contact Supplier

    pharmacompass-1-m-2026-01-12

    Virtual Booth

    Contact Supplier

    LGM Pharma accelerates & optimizes the new product pathway from early development through commercialization.https://marketing.lgmpharma.com/LGM-CDMO

    Virtual Booth

    Contact Supplier

    Vamsi Labs is one of the major manufacturers of Anti-asthmatic, Anti-migraine & Anti-psychotic APIs.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-2026-02-09

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    ACTIVE PHARMA INGREDIENTS

    DEVELOPMENTS

    FINISHED DOSAGE FORMULATIONS

    EXCIPIENTS

    INSPECTIONS & REGISTRATIONS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    Alkermes is a leader in innovative medicines that address the unmet needs and challenges of people living with debilitating diseases. As a fully integrated global biopharmaceutical company, Alkermes applies our scientific expertise, proprietary technologies and global resources to develop products that are designed to make a meaningful difference in the way patients manage their disease.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    Alkermes PlcIreland Flag
    Country
    Country
    Ireland
    Address
    Address
    Connaught House, 1 Burlington Road, Dublin 4, Ireland
    Telephone
    Telephone
    +353 1 772 8000
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://www.alkermes.com/
    Linkedin
    Linkedin
    https://www.linkedin.com/company/alkermes/?originalSubdomain=in
    youtube
    YouTube
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    Default Event

    International Sweetener Colloquium

    Not Confirmed

    envelop Contact Supplier

    International Sweetener Colloquium

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Alkermes Acquires Avadel Pharma, Expanding Into Sleep Medicine
    Alkermes Acquires Avadel Pharma, Expanding Into Sleep Medicine

    12 Feb 2026

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20260211590882/en/Alkermes-plc-Completes-Acquisition-of-Avadel-Pharmaceuticals-plc-Accelerating-Entry-Into-Sleep-Medicine-Market

    BUSINESSWIRE
    12 Feb 2026
    Share Share
    Alkermes to Report Q4, Year-End Results on Feb. 25, 2026
    Alkermes to Report Q4, Year-End Results on Feb. 25, 2026

    11 Feb 2026

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20260210073328/en/Alkermes-to-Report-Fourth-Quarter-and-Year-End-Financial-Results-on-Feb.-25-2026

    BUSINESSWIRE
    11 Feb 2026
    Share Share
    Avadel Pharma Announces Outcome of the Court Sanction Hearing
    Avadel Pharma Announces Outcome of the Court Sanction Hearing

    10 Feb 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/02/10/3235774/0/en/Avadel-Pharmaceuticals-Announces-Outcome-of-the-Court-Sanction-Hearing.html

    GLOBENEWSWIRE
    10 Feb 2026
    Share Share
    Avadel Pharma Shareholders Approve Acquisition By Alkermes
    Avadel Pharma Shareholders Approve Acquisition By Alkermes

    12 Jan 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/01/12/3217352/0/en/Avadel-Pharmaceuticals-Announces-that-Avadel-Shareholders-Approve-the-Proposed-Acquisition-by-Alkermes.html

    GLOBENEWSWIRE
    12 Jan 2026
    Share Share
    Alixorexton Receives FDA Breakthrough Therapy Designation
    Alixorexton Receives FDA Breakthrough Therapy Designation

    06 Jan 2026

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20260106871102/en/Alixorexton-Granted-Breakthrough-Therapy-Designation-by-U.S.-FDA-for-the-Treatment-of-Narcolepsy-Type-1

    BUSINESSWIRE
    06 Jan 2026
    Share Share
    Alkermes To Present At J.P. Morgan Healthcare Conference
    Alkermes To Present At J.P. Morgan Healthcare Conference

    30 Dec 2025

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20251229760927/en/Alkermes-to-Present-at-the-44th-Annual-J.P.-Morgan-Healthcare-Conference

    BUSINESSWIRE
    30 Dec 2025
    Share Share

    Excipients

    Click here to find the perfect excipient manufacturers by their capabilities

    Inspections and registrations

    Upload your audits for free, ask us

    ABOUT THIS PAGE

    Contact Alkermes Plc and get a quotation

    Alkermes Plc is a supplier offers 12 products (APIs, Excipients or Intermediates).

    Find a price of Sirolimus bulk with DMF, JDMF offered by Alkermes Plc

    Find a price of Dead On Polystyrene bulk with DMF offered by Alkermes Plc

    Find a price of Dimethyl Sulfoxide bulk with DMF offered by Alkermes Plc

    Find a price of Dl-Threo-3,4-Dihydroxyphenylserine bulk offered by Alkermes Plc

    Find a price of Fluvoxamine bulk offered by Alkermes Plc

    Find a price of Meloxicam bulk offered by Alkermes Plc

    Find a price of Morphine Sulfate bulk offered by Alkermes Plc

    Find a price of N1714 TABLETS bulk offered by Alkermes Plc

    Find a price of PROLEASE DILUENT USED FOR SUSPENSION OF PROLEASE MICROSPHERE PRODUCTS FOR PRODUCT ADMINISTRATION bulk offered by Alkermes Plc

    Find a price of N1679 NANOCRYSTAL CAPSULE bulk offered by Alkermes Plc

    Find a price of N1752 EXTENDED RELEASE TABLETS, 18MG bulk offered by Alkermes Plc

    Find a price of ELND-005 bulk offered by Alkermes Plc

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search